RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
57.93
0.00 (0.00%)
At close: Feb 24, 2026, 4:00 PM EST
57.98
+0.05 (0.09%)
After-hours: Feb 24, 2026, 7:46 PM EST
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $1.79 billion as of February 24, 2026. Its market cap has increased by 1,050.01% in one year.
Market Cap
1.79B
Enterprise Value
1.64B
1-Year Change
1,050.01%
Ranking
Category
Stock Price
$57.93
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has increased from $276.64M to $1.79B, an increase of 547.54%. That is a compound annual growth rate of 34.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 1.79B | 90.86% |
| Dec 31, 2025 | 938.57M | 340.16% |
| Dec 31, 2024 | 213.23M | -75.05% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 1.83B |
| Pharvaris | 1.80B |
| Galecto | 1.79B |
| Tyra Biosciences | 1.78B |
| Recursion Pharmaceuticals | 1.77B |
| Agios Pharmaceuticals | 1.77B |
| Innoviva | 1.75B |
| MBX Biosciences | 1.73B |